Albireo Pharma Q3 EPS $(1.73) Misses $(1.56) Estimate, Sales $1.385M Beat $960K Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(1.73) per share which missed the analyst consensus estimate of $(1.56) by 10.9 percent. This is a 47.86 percent decrease over losses of $(1.17) per share from

Benzinga · 11/06/2019 12:49

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(1.73) per share which missed the analyst consensus estimate of $(1.56) by 10.9 percent. This is a 47.86 percent decrease over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $1.385 million which beat the analyst consensus estimate of $960 thousand by 44.27 percent. This is a 484.39 percent increase over sales of $237 thousand the same period last year.